Weimer R, Daniel V, Pomer S, Opelz G
Department of Transplantation Immunology, University of Heidelberg, Federal Republic of Germany.
Transplantation. 1989 Oct;48(4):572-5.
In a prospective study we investigated the association of kidney graft rejection with pre- and posttransplant B cell responses in vitro after stimulation with pokeweed mitogen, Staphylococcus aureus Cowan I (SAC I), or donor lymphocytes. B cell differentiation was assessed in a reverse hemolytic plaque assay. Elevated pretransplant PWM- or SAC I-stimulated B cell responses were found to define patients with a high incidence of rejection episodes in the first 30 days posttransplant (P less than 0.005 and P less than 0.05, respectively). Elevated pretransplant donor cell-stimulated B cell responses were associated with a high risk of irreversible rejection (P less than 0.005). A posttransplant rise in donor cell-stimulated B cell responses was associated with an increase risk of a subsequent rejection crisis (P less than 0.05). Our data suggest that patients at risk of early rejection may identified by pretransplant testing of B cell responses.
在一项前瞻性研究中,我们调查了肾移植排斥反应与移植前及移植后经美洲商陆有丝分裂原、金黄色葡萄球菌考恩I型(SAC I)或供体淋巴细胞刺激后的体外B细胞反应之间的关联。通过反向溶血空斑试验评估B细胞分化。发现移植前经美洲商陆有丝分裂原或SAC I刺激的B细胞反应升高可确定移植后30天内排斥反应发生率高的患者(分别为P<0.005和P<0.05)。移植前供体细胞刺激的B细胞反应升高与不可逆排斥的高风险相关(P<0.005)。移植后供体细胞刺激的B细胞反应升高与随后排斥危机风险增加相关(P<0.05)。我们的数据表明,早期排斥反应风险较高的患者可通过移植前B细胞反应检测来识别。